Phio Scientific

Phio Scientific, founded in 2012 and based in Berlin, has developed a disruptive hardware-software platform for automated, continuous live cell analysis. Its core innovation is the patented, lens-free Cellwatcher imager, which works inside any incubator and feeds data to the cloud-based PHIOme platform for AI-driven analysis and visualization. The system addresses key pain points in life science research by replacing manual, endpoint assays with objective, real-time data, aiming to improve reproducibility, save time, and reduce costs. Phio targets academic, biotech, and pharma research labs conducting cancer research, immunology, drug discovery, and toxicology studies.

Integrated live cell monitoring platform combining the lens-free, incubator-compatible Cellwatcher imager with the cloud-based AI analytics platform PHIOme for continuous, automated cell analysis.

Competes against high-end automated microscope systems (e.g., from Sartorius, Thermo Fisher) and simpler endpoint imagers. Differentiation lies in the unique lens-free hardware enabling continuous incubator monitoring, combined with a dedicated cloud AI platform for automated analysis, targeting a niche for hands-off, real-time kinetic data.